Gennex Laboratories Ltd
BSE:531739

Watchlist Manager
Gennex Laboratories Ltd Logo
Gennex Laboratories Ltd
BSE:531739
Watchlist
Price: 12.71 INR -2.46%
Market Cap: 3.1B INR

Operating Margin

10.2%
Current
Declining
by 1.6%
vs 3-y average of 11.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.2%
=
Operating Income
₹152.7m
/
Revenue
₹1.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.2%
=
Operating Income
₹152.7m
/
Revenue
₹1.5B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Gennex Laboratories Ltd
BSE:531739
3.1B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...

Market Distribution

In line with most companies in India
Percentile
61st
Based on 5 437 companies
61st percentile
10.2%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Gennex Laboratories Ltd
Glance View

Market Cap
3.1B INR
Industry
Pharmaceuticals

Gennex Laboratories Ltd. engages in the manufacture of bulk drugs and intermediates products. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the business of manufacturing of bulk drugs, intermediaries and biotech products. The firm has a robust product portfolio spread over major product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal. The firm operates through Pharmaceutical Products (Bulk Drugs) segment. The firm's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/USP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Chlorphenesin IP/BP, which is anti-fungal, and Melitracen Hcl, which is an antidepressant. The firm has manufacturing facilities in India which caters to both domestic and international markets.

GENNEX Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
10.2%
=
Operating Income
₹152.7m
/
Revenue
₹1.5B
What is Gennex Laboratories Ltd's current Operating Margin?

The current Operating Margin for Gennex Laboratories Ltd is 10.2%, which is below its 3-year median of 11.8%.

How has Operating Margin changed over time?

Over the last 3 years, Gennex Laboratories Ltd’s Operating Margin has increased from 4.9% to 10.2%. During this period, it reached a low of 4.9% on Aug 30, 2022 and a high of 16.9% on Mar 31, 2024.

Back to Top